는 전략을 만들 수 있으며, 빈번하게 궤양을 일으키는 여러 경로의 위험한 상호작용을 예방할 수 있을 것이다. 그러나 이러한 전략을 실시해도 발궤양은 좀처럼 줄어들지 않 는다. 최근의 연구는, 환자에서 발관리 실천에 영향을 주는 심리적요소가 당뇨병 발궤양 발 생에 중요하다고 강조하고 있다. 증상에 의한 환자 자신의 위험인지와 자기관리의 효과 확신이 환자의 예방적 발관리 행동과 밀접하게 관계한다는 연구가 있다. 예방적 전략의 개발에서 이러한 면의 고려도 펼요하다. 그림 2. 당뇨발궤양에 이르는 경로 05_발궤양의 병태생리 27
참고 문헌 1. Abbott CA, Vileikyte L, Williamson S et al. Multicenter study of the incidence of and predictive risk factors for diabetic neurophatic foot ulceration. Diabetes Care 1998;7: 1071-1075. 2. Apelqvist J, Larsson J, Agardh C-D, Stenström A. The influence of external precipitating factors and peripheral neuropathy on the development and outcome of diabetic foot ulcers. J Diabetes Complic 1990;4:21-25. 3. Arkkila PET, Kantola IM, Viikari JSA. Limited joint mobility in non-insulin dependent diabetic (NIDDM) patients: correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications. J Diabetes Compl 1997;11(4):208-217. 4. Armstrong DG, Lavery LA, Harkless LB. Who is at risk for diabetic foot ulceration? Clin Podiatr Med Surg 1998;1:11-19. 5. Barnett SJ, Shield JPH, Potter MJ, Baum JD. Foot pathology in insulin dependent diabetes. Arch Dis Child 1995;73:151-153. 6. Birke JA, Rolfsen RJ. Evaluation of a self-administered sensory testing tool to Identify patients at risk of diabetes-related foot problems. Diabetes Care 1998;21(1):23-25. 7. Boulton AJM. The pathogenesis of diabetic foot problems: an overview. Diabetic Med 1996;13 (suppl 1):S12-S16. 8. Bridges RM Jr,. Deitch EA. Diabetic foot infections. Pathophysiology and treatment. Surg Clin N Am 1994;74(3):537-585. 9. Cavanagh PR, Ulbrecht JS, Caputo GM. The non-healing diabetic wound: fact or fiction? Osteotomy Wound Manage 1998;44(suppl 3a):6-13. 10. DelbridgeL, Ctercteko G, Fowler C, Reeve TS, LeSquesne LP. The aetiology of diabetic neuropathic ulceration of the foot. Br J Surg 1985;72:1-6. 11. Hehenberger K, Kratz G, Hansson A, Brismar K: Fibroblasts derived from human chronic diabetic wounds have a decreased proliferation rate, which is recovered by the addition of heparin. J Dermatol Sci 1998;2:144-151. 12. Hehenberger K, Hansson A. High glucose in the use growth factor resistance in human fibroblast can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochem 1997;3:197-201. 13. Jorneskog G, Brismar K, Fagrell B. Skin capillary circulation is more impaired in the toes of diabetic than non-diabetic patients with peripheral vascular disease. Diabetic Med 1995;12:36-41. 28 <strong>당뇨발병변</strong> <strong>진료지침</strong>